Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-19
DOI
10.1038/srep46528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
- (2016) Mahmoud A. ElSohly et al. BIOLOGICAL PSYCHIATRY
- A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
- (2016) Samuel T. Wilkinson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
- (2015) Deborah S. Hasin et al. JAMA Psychiatry
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Adverse Health Effects of Marijuana Use
- (2014) Nora D. Volkow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
- (2013) Wendy Swift et al. PLoS One
- Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
- (2012) Angelo A Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review
- (2012) Derik Hermann et al. CURRENT PHARMACEUTICAL DESIGN
- A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
- (2012) Antonio Waldo Zuardi et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention
- (2012) Sarah W. Feldstein Ewing et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
- (2011) Antonio Waldo Zuardi et al. PSYCHOPHARMACOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- The Dual Effects of Δ9-Tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration
- (2010) Surang Leelawat et al. CANCER INVESTIGATION
- Cannabis-based medicines in multiple sclerosis – A review of clinical studies
- (2010) David J. Rog IMMUNOBIOLOGY
- Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*
- (2010) Zlatko Mehmedic et al. JOURNAL OF FORENSIC SCIENCES
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana.
- (2009) Jane Metrik et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started